Southeast BIO is a regional non-profit organization that fosters the growth of the life sciences industry in the Southeastern United States through efforts that promote entrepreneurship and bring together the key players active in the development of the industry. SEBIO’s geographic footprint presently includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia (click on the map to the right to learn more about Biotech in each of these states).

 

About the Southeast

The Southeast United States is home to a thriving life sciences community as evidenced by more than 1,600 biopharmaceutical and medical technology companies located in the region (Battelle/BIO State Bioscience Industry Development Report). Regional universities, which report over $7.9 billion in research expenditures annually (NSF Higher Education Research and Development), help create a robust technology pipeline to spur new company formation. The region is home to several venture capital funds with a life sciences focus and in 2012, approximately 22% of the almost $1.2 billion of venture capital invested in the Southeast was invested in the life sciences industry (PricewaterhouseCoopers MoneyTree™ Report). With an exceptional quality of life, top research universities, low cost of living, and a desirable climate, the Southeast attracts and sustains entrepreneurial visionaries from throughout the world, which contribute to the region’s rising reputation as a community ripe for commercialization success.

 

 

 

 

To learn more about the biotech activity in the seven Southeastern states included in the SEBIO footprint, see below.
Tennessee Virginia North Carolina South Carolina Georgia Florida Alabama